Blood Markers of Early Pancreas Cancer
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.
Conditions:
🦠 Diabetes Mellitus, Type 2 🦠 PreDiabetes 🦠 Pancreas Cyst 🦠 Chronic Pancreatitis 🦠 Genetic Predisposition to Disease 🦠 Inherited Disease
🗓️ Study Start (Actual) 26 July 2018
🗓️ Primary Completion (Estimated) July 2028
✅ Study Completion (Estimated) July 2028
👥 Enrollment (Estimated) 1250
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Omaha, Nebraska, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

      Inclusion Criteria:

      • 1. Age ≥19
      • 2. Able to provide written, informed consent
      • 3. Able to to attend an in-person study visit in Omaha, NE twice a year to collect blood samples

      Exclusion Criteria:

      • 1. Personal history of PDAC
      • 2. Currently receiving treatment for a cancer diagnosis (excluding long-term hormonal therapy)
      • 3. Pre-diabetes on metformin for ≥ 3 years
Ages Eligible for Study: 19 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 13 June 2018
  • First Submitted that Met QC Criteria 13 June 2018
  • First Posted 26 June 2018

Study Record Updates

  • Last Update Submitted that Met QC Criteria 20 February 2024
  • Last Update Posted 21 February 2024
  • Last Verified February 2024